advertisement
Classification List
- 1 General aspects0
- 1.1 Epidemiology15
- 1.2 Population genetics0
- 1.3 Pathogenesis4
- 1.4 Quality of life8
- 1.5 Glaucomas as cause of blindness11
- 1.6 Prevention and screening4
- 2 Anatomical structures in glaucoma0
- 2.1 Conjunctiva3
- 2.2 Cornea20
- 2.3 Sclera8
- 2.4 Anterior chamber angle5
- 2.5 Meshwork0
- 2.5.1 Trabecular meshwork18
- 2.5.2 Schlemms canal3
- 2.5.3 Scleral outlet channels0
- 2.6 Aqueous humor dynamics0
- 2.6.1 Production1
- 2.6.2 Outflow0
- 2.6.2.1 Trabecular meshwork4
- 2.6.2.2 Uveoscleral0
- 2.6.3 Compostion3
- 2.7 Episcleral veins and venous pressure0
- 2.8 Iris6
- 2.9 Ciliary body2
- 2.10 Lens1
- 2.11 Vitreous body0
- 2.12 Choroid, peripapillary choroid, peripapillary atrophy9
- 2.13 Retina and retinal nerve fibre layer29
- 2.14 Optic disc28
- 2.15 Optic nerve1
- 2.16 Chiasma and retrochiasmal central nervous system6
- 2.17 Stem cells3
- 2.20 Other0
- 3 Laboratory methods0
- 3.1 Microscopy1
- 3.2 Electron microscopy1
- 3.3 Immunohistochemistry0
- 3.4 Molecular genetics0
- 3.4.1 Linkage studies0
- 3.4.2 Gene studies20
- 3.5 Molecular biology incl. SiRNA14
- 3.6 Cellular biology27
- 3.7 Biochemistry8
- 3.8 Pharmacology12
- 3.9 Pathophysiology4
- 3.10 Immunobiology5
- 3.11 Pharmacogenetics0
- 3.12 Proteomics1
- 3.13 In vivo imaging0
- 3.13.1 Laser Scanning0
- 3.13.1.1 Confocal Scanning Laser Ophthalmoscopy0
- 3.13.1.2 Confocal Scanning Laser Polarimetry0
- 3.13.2 Optical Coherence Tomography0
- 3.13.2.1 Anterior Segment1
- 3.13.2.2 Posterior Segment0
- 3.13.3 RGC Imaging0
- 3.13.4 Other0
- 3.20 Other0
- 4 Tissue culture of ocular cells0
- 5 Experimental glaucoma; animal models0
- 5.1 Rodent17
- 5.2 Primates3
- 5.3 Other9
- 6 Clinical examination methods0
- 6.1 Intraocular pressure measurement; factors affecting IOP0
- 6.1.1 Devices, techniques6
- 6.1.2 Fluctuation, circadian rhythms2
- 6.1.3 Factors affecting IOP17
- 6.2 Tonography, aqueous flow measurement (see also 2.6)1
- 6.3 Biomicroscopy (slitlamp)0
- 6.3.1 Anterior segment0
- 6.3.2 Posterior segment2
- 6.4 Gonioscopy0
- 6.5 Ophthalmoscopy0
- 6.6 Visual field examination and other visual function tests0
- 6.6.1 Conventional manual0
- 6.6.2 Automated23
- 6.6.3 Special methods (e.g. color, contrast, SWAP etc.)4
- 6.7 Electro-ophthalmodiagnosis5
- 6.8 Photography0
- 6.8.1 Anterior segment0
- 6.8.2 Posterior segment5
- 6.9 Computerized image analysis0
- 6.9.1 Laser scanning0
- 6.9.1.1 Confocal Scanning Laser Ophthalmoscopy10
- 6.9.1.2 Confocal Scanning Laser Polarimetry3
- 6.9.2 Optical coherence tomography0
- 6.9.2.1 Anterior4
- 6.9.2.2 Posterior40
- 6.9.5 Other2
- 6.10 Fluorescein (ICG) angiography0
- 6.10.1 Anterior segment0
- 6.10.2 Posterior segment0
- 6.11 Bloodflow measurements 19
- 6.12 Ultrasonography and ultrasound biomicroscopy4
- 6.13 Provocative tests5
- 6.19 Telemedicine3
- 6.20 Progression13
- 6.30 Other3
- 8 Refractive errors in relation to glaucoma0
- 8.1 Myopia3
- 8.2 Hypermetropia0
- 8.3 Contact lenses0
- 8.4 Refractive surgical procedures0
- 8.5 Other0
- 9 Clinical forms of glaucomas0
- 9.1 Developmental glaucomas0
- 9.1.1 Congenital glaucoma, Buphthalmos9
- 9.1.2 Juvenile glaucoma6
- 9.1.3 Syndromes of Axenfeld, Rieger, Peters, aniridia1
- 9.1.4 Other0
- 9.2 Primary open angle glaucomas0
- 9.2.1 Ocular hypertension1
- 9.2.2 Other risk factors for glaucoma14
- 9.2.3 Open angle glaucoma with elevated IOP2
- 9.2.4 Normal pressure glaucoma8
- 9.3 Primary angle closure glaucomas0
- 9.3.1 Acute primary angle closure glaucoma (pupillary block)8
- 9.3.2 Chronic primary angle closure glaucoma (pupillary block)3
- 9.3.3 Plateau iris syndrome1
- 9.3.4 Primary angle closure suspect1
- 9.3.5 Primary angle closure6
- 9.3.10 Other0
- 9.4 Glaucomas associated with other ocular and systemic disorders0
- 9.4.1 Steroid-induced glaucoma4
- 9.4.2 Glaucomas associated with disorders of the cornea, conjunctiva, sclera0
- 9.4.2.1 Iridocorneal endothelial syndrome (ICE, incl. irisatrophy)1
- 9.4.2.2 Posterior polymorphous dystrophy0
- 9.4.2.3 Fuchs' endothelial dystrophy1
- 9.4.2.5 Other1
- 9.4.3 Glaucomas associated with disorders of the iris and ciliary body0
- 9.4.3.1 Pigmentary glaucoma1
- 9.4.3.5 Other0
- 9.4.4 Glaucomas associated with disorders of the lens0
- 9.4.4.1 Exfoliation syndrome10
- 9.4.4.2 Glaucomas associated with cataracts0
- 9.4.4.3 Glaucomas associated with lens dislocation0
- 9.4.4.5 Other0
- 9.4.5 Glaucomas associated with disorders of the retina, choroid and vitreous0
- 9.4.5.1 Neovascular glaucoma8
- 9.4.5.5 Other7
- 9.4.6 Glaucomas associated with inflammation, uveitis 9
- 9.4.7 Glaucomas associated with ocular trauma0
- 9.4.8 Glaucomas associated with intraocular tumors8
- 9.4.9 Glaucomas associated with elevated episcleral venous pressure0
- 9.4.10 Glaucomas associated with hemorrhage3
- 9.4.11 Glaucomas following intraocular surgery0
- 9.4.11.1 Ciliary block (malignant) glaucoma2
- 9.4.11.2 Glaucomas in aphakia and pseudophakia9
- 9.4.11.3 Epithelial, fibrous, and endothelial proliferation0
- 9.4.11.4 Glaucomas associated with corneal surgery8
- 9.4.11.5 Glaucomas associated with vitreoretinal surgery9
- 9.4.15 Glaucoma in relation to systemic disease30
- 9.4.20 Other0
- 10 Differential diagnosis e.g. anterior and posterior ischemic optic neuropathy1
- 11 Medical treatment0
- 11.1 General management, indication1
- 11.2 Cholinergic drugs1
- 11.3 Adrenergic drugs0
- 11.3.1 Epinephrine0
- 11.3.2 Thymoxamine, dapiprazole0
- 11.3.3 Apraclonidine, brimonidine0
- 11.3.4 Betablocker4
- 11.3.5 Other0
- 11.4 Prostaglandins14
- 11.5 Carbonic anhydrase inhibitors0
- 11.5.1 Systemic0
- 11.5.2 Topical1
- 11.6 Osmotic treatment0
- 11.7 Treatment of bloodflow0
- 11.8 Neuroprotection22
- 11.9 Gene therapy2
- 11.13 Combination therapy0
- 11.13.1 Betablocker and pilocarpine0
- 11.13.2 Betablocker and carbon anhydrase inhibitor0
- 11.13.3 Betablocker and brimonidine0
- 11.13.4 Betablocker and prostaglandin2
- 11.13.5 Other0
- 11.14 Investigational drugs; pharmacological experiments10
- 11.15 Other drugs in relation to glaucoma6
- 11.16 Vehicles, delivery systems, pharmacokinetics, formulation15
- 11.17 Cooperation with medical therapy e.g. persistency, compliance, adherence6
- 11.20 Other0
- 12 Surgical treatment0
- 12.1 General management, indication1
- 12.2 Laser iridotomy2
- 12.3 Laser iridoplasty0
- 12.4 Laser trabeculoplasty and other laser treatment of the angle7
- 12.7 Surgical iridectomy0
- 12.8 Filtering surgery0
- 12.8.1 Without tube implant11
- 12.8.2 With tube implant or other drainage devices15
- 12.8.3 Non-perforating8
- 12.8.4 Using laser0
- 12.8.5 Other0
- 12.8.10 Woundhealing antifibrosis12
- 12.8.11 Complications, endophthalmitis7
- 12.9 Trabeculotomy, goniotomy6
- 12.10 Cyclodestruction5
- 12.11 Cyclodialysis1
- 12.12 Cataract extraction0
- 12.12.1 Intracapsular0
- 12.12.2 Extracapsular0
- 12.12.3 Phacoemulsification5
- 12.14 Combined cataract extraction and glaucoma surgery0
- 12.14.1 Intracapsular0
- 12.14.2 Extracapsular0
- 12.14.3 Phacoemulsification7
- 12.15 Capsulotomy0
- 12.16 Vitrectomy0
- 12.17 Anesthesia1
- 12.20 Other 0
- 13 Therapeutic prognosis and outcome0
- 13.1 Prognostic factors0
- 13.2 Outcome0
- 13.2.1 IOP3
- 13.2.2 Visual field1
- 13.2.2.1 Progression0
- 13.2.2.2 Improvement0
- 13.2.3 Other1
- 14 Costing studies; pharmacoeconomics0
- 15 Miscellaneous17